Pharmacokinetics, Pharmacodynamics, and Safety of Evocalcet (KHK7580), a Novel Calcimimetic Agent: An Open-Label, Single- and Multiple-Dose, Phase I Trial in Healthy Chinese Subjects

Xuemei He,1 Kazuya Narushima,2 Masahiro Kojima,2 Chisato Nagai,2 Kexin Li1 1Clinical Trial Center, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Applic...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	He X, Narushima K, Kojima M, Nagai C, Li K
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Dove Medical Press 2024-02-01
Reeks:	Drug Design, Development and Therapy
Onderwerpen:	evocalcet calcimimetic agents secondary hypoparathyroidism pharmacokinetic pharmacodynamic safety
Online toegang:	https://www.dovepress.com/pharmacokinetics-pharmacodynamics-and-safety-of-evocalcet-khk7580-a-no-peer-reviewed-fulltext-article-DDDT
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!